Medical device designers, tissue engineers, and clinical engineering specialists, your complete H1B guide for 2026.
Biomedical engineering (SOC 17-2031) sits at the intersection of engineering and life sciences, encompassing medical device design, biomechanics, tissue engineering, clinical instrumentation, and regulatory affairs engineering. The field requires at minimum a bachelor's degree in biomedical engineering, bioengineering, or a closely related discipline, clearly satisfying the specialty occupation threshold.
The leading industries sponsoring biomedical engineers on H1B include: medical device manufacturers (Medtronic, Boston Scientific, Abbott, Stryker, Zimmer Biomet, Edwards Lifesciences), diagnostic imaging companies (GE HealthCare, Siemens Healthineers, Philips Healthcare), in vitro diagnostics firms (Bio-Rad, Becton Dickinson, Hologic), pharmaceutical companies with device components (combination product developers), and hospital systems with biomedical engineering departments.
Biomedical engineers are also employed in regulatory affairs at Class II and Class III medical device companies, conducting FDA 510(k) submissions, PMA applications, and post-market surveillance engineering. These roles require deep understanding of FDA Quality System Regulation (21 CFR Part 820) and ISO 13485, knowledge that is distinctly tied to biomedical engineering education and training.
Startups in digital health, wearable medical devices, and surgical robotics are active H1B sponsors. Companies like Intuitive Surgical, Axonics Modulation Technologies, Nevro Corp, and NovaBay Pharmaceuticals have sponsored international biomedical engineering talent. The medtech startup ecosystem in San Francisco, Boston, Minneapolis, and Research Triangle Park is particularly active.
SOC 17-2031 (Biomedical Engineers) covers design, testing, and evaluation of biomedical equipment, devices, and systems. However, biomedical engineers in specific subfields may also be classified under: 17-2199 (Engineers, All Other) for niche biomechanics or neural engineering roles; 19-1029 (Biological Scientists, All Other) for roles emphasizing biological research over engineering design; or 29-2099 (Health Technologists and Technicians, All Other) for clinical engineering and equipment management roles in hospitals.
Specialty occupation RFEs in biomedical engineering sometimes arise for roles with titles like 'clinical specialist' or 'applications engineer' where the duties may appear to be more commercial or support-oriented than engineering-based. Counter this by ensuring the job description emphasizes engineering analysis, technical design review, or regulatory engineering activities rather than sales support or customer service functions.
For FDA regulatory engineers (design controls, risk management per ISO 14971, FMEA, usability engineering), the specialty occupation argument is straightforward: these activities directly apply biomedical engineering coursework in medical device design, biological system interactions, and regulatory science. Include the specific FDA guidance documents and standards that the role requires knowledge of.
Tissue engineering and regenerative medicine roles may benefit from dual SOC code analysis. If the role primarily involves biomaterial synthesis and cell culture, it may be more accurately described under biological sciences. If it involves design of scaffolds, bioreactor engineering, or manufacturing process development, SOC 17-2031 or a materials engineering code may be more appropriate.
Prevailing wages under SOC 17-2031 are generally moderate to strong. At Level II, they range from approximately $85,000–$100,000 in mid-tier markets and $105,000–$130,000 in major medtech hubs like the San Francisco Bay Area and Boston. Minneapolis (home to Medtronic's global headquarters) shows Level II wages around $90,000–$110,000.
Biomedical engineers in regulatory affairs or quality assurance at mid-to-senior levels often earn above the Level II prevailing wage. Ensure the LCA wage level accurately reflects the complexity of the position, a principal quality systems engineer with 10 years of ISO 13485 and FDA QSR experience should be at Level III or IV.
Clinical biomedical engineers at hospitals (managing and servicing medical equipment) are covered by the same SOC 17-2031 classification. However, hospital-based roles may be certified under state wage databases rather than the national DOL surveys. Check the applicable state wage library in the FLC Data Center when filing LCAs for hospital biomedical engineering positions.
H1B petitions for biomedical engineers at academic medical centers, Johns Hopkins, Mayo Clinic, Massachusetts General Hospital, may qualify as cap-exempt if the employer is a nonprofit organization affiliated with an institution of higher education. This cap-exempt status allows filing outside the annual lottery, which is a significant advantage.
Medtronic, headquartered in Dublin, Ireland (with major U.S. operations in Minneapolis), is one of the world's largest medical device companies and a consistent H1B sponsor for biomedical, electrical, and software engineers. Their Cardiac Rhythm Management, Surgical Innovations, and Neuromodulation divisions have active international hiring programs.
Boston Scientific (Marlborough, MA), Abbott (Chicago), Stryker (Kalamazoo, MI), and Zimmer Biomet (Warsaw, IN) are all top-10 medical device companies with established H1B pipelines. These companies sponsor for R&D, manufacturing engineering, quality systems, and regulatory affairs roles. Their established compliance infrastructure makes sponsorship relatively efficient.
GE HealthCare (Chicago), Siemens Healthineers (US headquarters in Malvern, PA), and Philips Healthcare (US HQ in Cambridge, MA) sponsor biomedical and electrical engineers for diagnostic imaging hardware, software, and systems roles. These companies have strong diversity hiring programs and global mobility teams familiar with H1B processes.
Academic medical centers and research universities, while often cap-exempt, may have slower internal processes for H1B sponsorship than industry. If your target is an academic position, start the H1B process at least 6 months before your intended start date and verify the institution's immigration attorney contact early in the recruitment process.
PERM is the most common green card path. Biomedical engineering subspecialties with limited domestic pipelines, computational biomechanics, neural interface device design, advanced prosthetics R&D, often produce successful PERM certifications because recruitment genuinely yields few qualified U.S. workers.
EB-2 NIW is compelling for biomedical engineers contributing to public health outcomes. Work on FDA-cleared diagnostic devices, life-sustaining therapeutic devices, or infectious disease detection platforms has clear national importance. A well-crafted NIW petition with evidence of your specific contributions, publications, patents, or clinical deployment data, can succeed without employer sponsorship.
EB-1A is available for biomedical engineers with extraordinary ability: patents, publications in Nature Biomedical Engineering or IEEE TBME, invited talks at major conferences (BMES Annual Meeting, MRS), and press coverage or prizes. Senior researchers at academic labs transitioning to industry should evaluate their publication and patent record carefully for EB-1A eligibility.
For biomedical engineers at academic institutions, EB-1B (Outstanding Professor or Researcher) may also apply if the role involves primarily research and teaching. EB-1B requires showing recognition of outstanding achievement in the academic field, typically 3+ years of research experience plus international recognition through publications, citations, editorial board service, or peer review.
H1B Visa Jobs Editorial Team
Senior Immigration Attorney
15+ years specializing in employment-based immigration. Has helped thousands of professionals navigate U.S. visa processes.